Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Engineered biologics with conditional activation for precision cancer immunotherapy
Switch Biologics is a UK biotechnology company developing engineered protein biologics for cancer immunotherapy. The company applies directed evolution and protein engineering to build conditionally activated therapeutics that respond to two simultaneous molecular signals, a design intended to concentrate activity…
Multi-omic sequencing and genomics services
Source Genomics is a contract genomics laboratory providing multi-omic sequencing and analytical services to pharmaceutical, biotechnology, and academic clients. Services span Sanger sequencing, next-generation sequencing, Oxford Nanopore long-read sequencing, spatial transcriptomics, optical genome mapping, Olink…
Cell culture media, reagents, and instruments for life sciences
STEMCELL Technologies UK is the British subsidiary of STEMCELL Technologies Canada Inc., a privately held Canadian biotechnology company founded in 1993. The Cambridge facility serves as the company's European hub for sales, marketing, research and development, and customer training, supporting researchers across the…
GPCR-targeted small molecule therapeutics
Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate G protein-coupled receptor pathways. The company targets metabolic, inflammatory, and fibrotic diseases using an integrated drug discovery platform combining…
Bioanalytical, DMPK and analytical sciences CRO for drug development
Resolian UK is a contract research organisation specialising in bioanalysis, drug metabolism and pharmacokinetics, and analytical sciences services for pharmaceutical and biotechnology clients. Operating from purpose-built laboratories in Fordham, Cambridgeshire and Sandwich, Kent, the company delivers GxP and non-GMP…
Cambridge cancer research institute advancing discovery and clinical translation
Cancer Research UK Cambridge Institute is a cancer research institute within the University of Cambridge, investigating tumour biology, early detection and treatment. Its research groups study cancer evolution, genomics and the tumour microenvironment, using imaging and computational approaches to improve diagnosis…
Proteometer HPLC assay kits for therapeutic antibody analysis
Novilytic is a US biotechnology company with a UK commercial presence, developing analytical kits for therapeutic protein characterisation. Its Proteometer platform uses molecular-recognition chemistry and fluorescence-detected HPLC to measure monoclonal antibody concentration, aggregation and charge variants directly…
Digital cognitive assessment and CNS clinical trial software platform
Cambridge Cognition provides digital cognitive assessment and clinical trial technology for central nervous system drug development. Its validated computerised tests measure memory, attention and executive function across conditions including Alzheimer's disease and schizophrenia. The company also offers electronic…
Small molecule inhibitors targeting somatic expansion in neurodegeneration
LoQus23 Therapeutics is a biotechnology company developing oral small molecule inhibitors of DNA mismatch repair for the treatment of Huntington's disease and other triplet repeat expansion disorders. The company targets MutSβ, a protein complex whose aberrant activity drives somatic expansion and progressive…
Circular RNA therapeutics and scalable RNA production
RNAvate is a Cambridge biotechnology spinout developing circular RNA (circRNA) technologies for RNA medicines, founded from research at the MRC Laboratory of Molecular Biology. Its platform focuses on scalable circRNA synthesis and purification to support durable therapeutic protein expression. Published laboratory…
Genomics and biodata research campus near Cambridge
Wellcome Genome Campus is a 125-acre research campus in Hinxton, Cambridgeshire, owned by Wellcome. It is home to the Wellcome Sanger Institute, EMBL-EBI, Wellcome Connecting Science and the BioData Innovation Centre, an incubator for genomics and biodata companies. The campus houses nearly 3,000 researchers,…
Point-of-care diagnostics and AI triage for cancer patients
52North is a medical technology company developing diagnostics and digital tools for urgent cancer care. Its lead programme is a point-of-care blood test designed to help chemotherapy patients assess their risk of neutropenic sepsis outside hospital, alongside an AI-supported app for triaging acute oncology symptoms.…
3D multi-omics platform for genetically validated drug target discovery
Enhanced Genomics is a biotechnology company developing a proprietary 3D multi-omics platform that maps genome-wide chromatin interactions to identify genetically validated drug targets for common diseases. Using patented technology integrated with a human cell type-specific multi-omics atlas, the platform links…
Bioactive molecule delivery technologies for cell culture and therapeutics
Cell Guidance Systems is a biotech and reagents company developing technologies for the delivery of bioactive molecules, with applications in cell biology research, drug development, and biomanufacturing. Its technology addresses protein instability in cell culture by providing sustained, localised release of growth…
Integrated bioprocessing platform for biologics development and manufacture
Biologic Technologies is a developer of intelligent bioprocessing platforms for biologics development and manufacturing. Its platform integrates complete biological workflows into a single automated device, combining precision fluid handling, in-line process analytics, and AI-driven optimisation. Application-specific…
Research antibodies, proteins and ELISA kits for life science laboratories
Antibodies.com is a supplier of research reagents for life science laboratories, offering a catalogue of more than 100,000 products. Its range includes primary and secondary antibodies, recombinant proteins, ELISA kits and other assay kits used in applications such as western blotting, immunohistochemistry, flow…
First-in-class small molecule inhibitors of RNA-modifying enzymes
STORM Therapeutics is a clinical-stage biotechnology company pioneering the field of RNA epigenetics, developing small molecule inhibitors of RNA-modifying enzymes as a new class of cancer treatment. Its lead programme STC-15, a METTL3 inhibitor, was the first RNA-modifying enzyme inhibitor to enter human clinical…
Cancer genetics testing and contract research
Oncologica provides molecular cancer diagnostics and contract research services from its laboratory at Chesterford Research Park near Cambridge. Its Oncofocus testing uses tumour DNA profiling to help clinicians identify potentially relevant targeted treatments and immunotherapies. The company also develops…
Targeted protein degradation platform for neurodegenerative disease
TRIMTECH Therapeutics is a biotechnology company developing small-molecule degraders that selectively remove disease-causing protein aggregates while preserving the functional, non-aggregated forms of the same proteins. The platform is built on research into the E3 ubiquitin ligase TRIM21, conducted over nearly two…
Rapid diagnostic platforms for infectious disease and consumer testing
Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid isothermal nucleic acid amplification assays, and an Extreme Volume Manufacturing capability producing lateral flow diagnostic tests at…